The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Niraparib in metastatic pancreatic cancer after previous chemotherapy (NIRA-PANC): A phase 2 trial.
 
Anup Kasi
Research Funding - Halozyme (Inst); Novocure (Inst); Tesaro (Inst)
 
Prabhakar Chalise
No Relationships to Disclose
 
Stephen K. Williamson
Research Funding - Acceleron Pharma (Inst); Aleon Pharma (Inst); Astellas Pharma (Inst); Bayer Health (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Merck Serono (Inst); Nektar (Inst); Novartis (Inst); Pharmacyclics (Inst); Regeneron (Inst); Rogosin Institute (Inst); Sanofi (Inst); Seagen (Inst); Sotio (Inst)
 
Joaquina Celebre Baranda
Employment - Halozyme
Stock and Other Ownership Interests - Adaptimmune; Halozyme; Ignyta; Loxo
Research Funding - Novartis
 
Weijing Sun
Honoraria - Genentech/Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer
Research Funding - Bayer; Merck (Inst)
 
Raed Moh'd Taiseer Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - Amgen
Research Funding - EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Anwaar Saeed
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - AstraZeneca/MedImmune (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Lilly
 
Sean Kumer
No Relationships to Disclose
 
Timothy Schmitt
No Relationships to Disclose
 
Carolyn Foster
No Relationships to Disclose
 
Ziyan Y. Pessetto
Honoraria - QIAGEN
Travel, Accommodations, Expenses - Illumina
 
Malgorzata A. Witek
Patents, Royalties, Other Intellectual Property - in vitro capture and analysis of circulating tumor cells
Other Relationship - BioFluidica (I)
 
Steven A. Soper
Leadership - BioFluidica
Stock and Other Ownership Interests - BioFluidica
Honoraria - BioFluidica
Consulting or Advisory Role - BioFluidica
Research Funding - BioFluidica
Patents, Royalties, Other Intellectual Property - BioFluidica
Travel, Accommodations, Expenses - BioFluidica
Other Relationship - BioFluidica
 
Andrew K. Godwin
No Relationships to Disclose